Minggu, 05 Oktober 2008

Laparoscopic Versus Open Appendectomy: A Prospective Randomized Double-Blind Study.

Summary Background Data: The value of laparoscopy in appendicitis is not established. Studies suffer from multiple limitations. Our aim is to compare the safety and benefits of laparoscopic versus open appendectomy in a prospective randomized double blind study.Methods: Two hundred forty-seven patients were analyzed following either laparoscopic or open appendectomy. A standardized wound dressing was applied blinding both patients and independent data collectors. Surgical technique was standardized among 4 surgeons. The main outcome measures were postoperative complications. Secondary outcome measures included evaluation of pain and activity scores at base line preoperatively and on every postoperative day, as well as resumption of diet and length of stay. Activity scores and quality of life were assessed on short-term follow-up.Results: There was no mortality. The overall complication rate was similar in both groups (18.5% versus 17% in the laparoscopic and open groups respectively), but some early complications in the laparoscopic group required a reoperation. Operating time was significantly longer in the laparoscopic group (80 minutes versus 60 minutes; P = 0.000) while there was no difference in the pain scores and medications, resumption of diet, length of stay, or activity scores. At 2 weeks, there was no difference in the activity or pain scores, but physical health and general scores on the short-form 36 (SF36) quality of life assessment forms were significantly better in the laparoscopic group. Appendectomy for acute or complicated (perforated and gangrenous) appendicitis had similar complication rates, regardless of the technique (P = 0.181).Conclusions: Unlike other minimally invasive procedures, laparoscopic appendectomy did not offer a significant advantage over open appendectomy in all studied parameters except quality of life scores at 2 weeks. It also took longer to perform. The choice of the procedure should be based on surgeon or patient preference.
Introduction
Since its initial description by Semm[1] in 1983, laparoscopic appendectomy (LA) has struggled to prove its superiority over the open technique. This is in contrast to laparoscopic cholecystectomy, which has promptly become the gold standard for gallstone disease despite little scientific challenge.[2] Open appendectomy (OA) has withstood the test of time for more than a century since its introduction by McBurney:[3] the procedure is standardized among surgeons and, unlike cholecystectomy, OA is typically completed using a small right lower quadrant incision and postoperative recovery is usually uneventful. It is the second most common general surgical procedure performed in the United States, after laparoscopic cholecystectomy, and the most common intraabdominal surgical emergency, with a lifetime risk of 6%. The overall mortality of OA is around 0.3%; and morbidity, about 11%.[4] Given the large number of procedures done annually, the validation of a minimally invasive technique that would improve outcomes may have a direct impact on patient management and possibly an indirect effect on the economics of health care.
Numerous prospective randomized studies,[5-26] meta-analyses,[27-30] and systematic critical reviews[31-34] have been published on the topic of LA, with a general consensus that the heterogeneity of the measured variables and other weaknesses in the methodology have not allowed to draw definitive conclusions and generalizations.[33,34]
With this in mind, we have designed a prospective randomized study (PRS) comparing LA to OA that included double blinding of the patient and the independent data collector, a factor missing in all but 2 PRS.[11,23]

Minggu, 01 Juni 2008

PEDIATRIC-NEUROLOGY-FEBRILE SEZURES&NEUROPROTECTION

FEBRILE SEIZURES & NEUROPROTECTION


Neuroprotection: Preventing Epilepsy?
Traditionally, pharmacological neuroprotection is a concept primarily
associated with acute neurodegeneration due to cerebral ischemia or traumatic
brain injury. The goal of drug therapy in these settings is to restore the
normal biochemical environment and protect neurons from the cytotoxic
effects of inflammation and hyperexcitability. Anti-thrombotic, thrombolytic,
and anti-inflammatory agents are used in stroke and head injury to prevent
the sequelae of such insults to the brain. Recent studies of anticoagulation
with unfractionated heparin following ischemia and brain trauma in animal
models show a decrease in lesion size and improvement in motor and cognitive
deficits. Unfractionated heparin is believed to have not only anti-coagulant,
but anti-oxidant, anti-inflammatory, anti-excitatory, and neurotrophic effects that
may act synergistically to provide neuroprotection in acute brain insult. After
traumatic brain injury, neuroprotective therapy generally focuses on prevention
of secondary brain injury. Many pharmacotherapeutic agents are being investigated and a variety of promising therapeutic options have emerged,including glutamate receptor antagonists, calcium channel antagonists, and free radical scavengers.

A common theme in neuroprotection is prevention of seizures in patients who
are at increased risk for developing epilepsy. Potential causes of epilepsy include
cerebrovascular disease, perinatal hypoxia or ischemia, infection, febrile seizures,
tumors, congenital malformations, trauma, and status epilepticus. Underlying
genetic factors may also have a role in determining seizure susceptibility after an
insult. The ability of the anti-epileptic drugs to prevent epileptogenesis in at-risk
patients is largely unknown.

Clinical studies of phenytoin, phenobarbital, carbamazepine, and valproate
have failed to show a protective effect in the development of epilepsy after head
injury. Studies in animal models, though, have shown that valproate may be
effective in preventing epilepsy. These findings emphasize the complex multifactorial
nature of seizure development and emphasize the need for multifaceted
treatment strategies in epilepsy. Identifying the fundamental mechanisms of
epileptogenesis may allow us to develop therapies that target the underlying
disease process and effectively alter the development or progression of epilepsy.

There is undoubtedly a cascade of disparate events that occurs in the
development of epilepsy. A primary insult in the setting of genetic susceptibility
may lead to fundamental structural or biochemical changes that result in
spontaneous seizures and epilepsy. Pharmacotherapeutic strategies that can alter
the sequelae of brain injury, influence the process of epileptogenesis, prevent
or terminate seizure activity, modify underlying pathology, or interfere with
multidrug resistance mechanisms do have an essential role in the successful
treatment of patients with epilepsy.(Leonardo Oloan Agusta Sitanggang-FK.UNRI)
Terimakasih buat temen-temen yang udah mau baca&diharapkan komentar ny y....

PEDIATRIC-NEUROLOGY-FEBRILE SEZURES

FEBRILE SEIZURES

Febrile Seizures
Children between the ages of 3 months and 5 years have a lower seizure threshold
and are susceptible to febrile seizures. Up to 5% of children in the Medan
experience a febrile seizure by their fifth birthday. A simple febrile seizure does
not require workup with special blood tests, imaging studies, lumbar puncture
(unless other signs and symptoms of meningitis are present), or an electroencephalogram
(EEG). Children who experience a complex febrile seizure and have
a family history of epilepsy or developmental delay appear to have a higher risk
of developing afebrile seizures. Recurrent febrile seizures are more likely in patients
who had their first febrile seizure at a young age, a relatively low fever at
time of presentation with first seizure, a history of febrile seizures in a first-degree
relative, or a brief duration between fever onset and initial seizure. An initial
simple febrile seizure does not require treatment (except perhaps antipyretics and
treatment of the source of the fever), while other types of febrile seizures require
weighing the risk of further seizures against the risk of side effects from
anticonvulsants.

Type Subtypes
Partial (Focal) Simple
Complex
Partial seizures secondarily generalized

Generalized Absence
Tonic/Clonic
Myoclonic
Atonic

Unclassified


Simple febrile seizures, which are generalized and last less than 15 minutes, should be distinguished from complex events, which are prolonged, occur more than once
in 24 hours, or are focal. Although an abnormally high proportion of adults with
temporal lobe epilepsy have a history of febrile seizures, it is not clear whether subtle
structural abnormailities in these patients produced a lower seizure threshold during
childhood, or whether the febrile seizures were responsible for the development of
the seizure foci.


Seizure Classification
Seizures are classified according to the scheme of the International League Against. Epilepsy. Symptomatological, electrophysiological and imaging findings are needed to accurately classify epileptic events. Classification of seizure type
should not be confused with identification of a seizure focus, although these two
exercises overlap to some degree. Determination of the seizure focus is requisite
before deciding upon definitive therapies. The identification of a seizure focus also
requires detailed knowledge of the symptoms, electrophysiological findings, and the
results of imaging studies. In the current era, this often includes computed tomography
(CT), magnetic resonance imaging (MRI), positron emission tomography
(PET) and single photon emission computed tomography (SPECT).


Partial Seizures
Partial seizures are those that arise from a focal region of the cortex. They are
simple partial seizures if the discharges elicit disturbance of sensory or motor symptoms
without causing an alteration in consciousness. The symptoms that accompany
a seizure provide clues about the location of the focus. Children with simple
partial seizures in whom no lesion is identified are often not appropriate candidates
for resective surgery. Benign Epilepsy of Childhood with Rolandic Spikes, also called
Benign Rolandic Epilepsy, is an entity seen among children from 0 to 15 years old.
This entity is important to recognize as it responds well to pharmacological therapies
and seizures recede in all patients by age 15.


Complex Partial Seizures
Complex partial seizures are those that produce some alteration of consciousness,
such as visual or auditory hallucinations, a sense of deja vu, or some impairment
of contact with the outside world. The most frequent cause of such seizures is
mesial temporal sclerosis.


Generalized Seizures
Generalized seizures arise diffusely from the cerebral cortex. For making therapeutic
decisions, it is critical to distinguish between primary generalized seizures,
and focal seizures with secondary generalization. In the latter case, removal or disconnection of an isolated focus may prevent generalization.


Pharmacological Treatment
Pharmacological therapy depends very much on the classification of seizure type.
Seizure type may predict both the likelihood of improvement and the risk of clinical
deterioration in response to a given anticonvulsant. The general principles of pharmacotherapy are to begin with a single agent (monotherapy), increase the dose to
the maximum tolerable if seizures are refractory, and when maximized on
monotherapy, begin to add-on. Follow the maxim “start low, go slow.” Certain seizure
types respond to specific medications.(Leonardo Oloan Agusta Sitanggang-FK.UNRI)
Terimakasih buat temen-temen yang udah mau baca&diharapkan komentar ny y....

Jumat, 23 Mei 2008

PEDIATRIC-PHARMACOLOGY

Neuropathy and hepatotoxicity during therapy for leukemia.

PEDIATRIC-ANEMIA

Erythromycin induced hemolytic anemia.
A 3-year-old female receiving Pediazole (erythromycin ethylsuccinate and sulfisoxazole) for tonsillitis and otitis media developed severe hemolytic anemia. No serum drug-dependent antibodies could be demonstrated with an in vitro 'immune-complex' method using Pediazole, pure erythromycin ethylsuccinate or pure sulfisoxazole. However, a method using red cells coated with erythromycin base showed in vitro lysis of the erythromycin-coated red cells. This is only the second case of immune hemolytic anemia associated with erythromycin and the first where in vitro drug-dependent hemolysis was demonstrable. (Leonardo O.A.Stg-FK.UNRI)

Diharapkan komentar dari temen2 yach....